基于CRISPR-Cas9技术的基因治疗研究进展  

Research progress of CRISPR-Cas9 system for gene therapy

作　　者：詹长生 夏小雨[1] 

机构地区：[1]上海交通大学医学院,上海200025

出　　处：《生物工程学报》2016年第7期861-869,共9页Chinese Journal of Biotechnology

基　　金：国家自然科学基金(No.81501308);上海市卫生局科研项目(No.20134Y169)资助~~

摘　　要：CRISPR-Cas9系统是细菌在与噬菌体抗争的进化过程中产生的一种抵御外源DNA入侵的机制,能有效识别并剪切外源DNA。基于其识别切除外源DNA的原理,CRISPR-Cas9系统被开发成为新一代基因编辑工具。与ES打靶、ZFN、TALEN等技术途径相比,CRISPR-Cas9系统操作简便、效率高、成本低,有着极其广阔的应用前景。本文整理了近年内有关CRISPR-Cas9系统的最新文献报道,对该系统工作原理以及针对基因治疗的研究进展进行综述。The clustered regulatory interspaced short palindromic repeat-Cas9（CRISPR-Cas9） system is the part of the prokaryotic immune system, which could recognize and delete the exogenous sequences originated from virus or plasmid. Based on its mechanism, CRISPR-Cas9 system was developed into the new generation of gene editing tool. Compared to the existed technologies such as ES targeting, ZFN or TALEN, CRISPR-Cas9 system is a more efficient, economical and promising approach to manipulate the genome. In this review, we summarize the research progress about CRISPR-Cas9 technology, especially the latest applications in gene therapy studies of human diseases.

关 键 词：CRISPR-Cas9技术 基因编辑 疾病模型 基因治疗 个性化医疗 

分 类 号：R450[医药卫生—治疗学]